See how these trends are reshaping pharmacy
As new but more expensive drugs continue to enter the market, managing the rising cost of prescription drugs has become even more difficult for plan sponsors.
We’ve outlined 3 ways to tackle these trends.
- Harness the powers of biosimilars
- Apply clinical rigor to weight loss drugs
- Account for gene therapy risk

The next biosimilar wave has arrived. Now what?
In this conversation, learn about a new class of biosimilars and what this means for competition, cost and volume in the PBM market.

Gene therapy: How to prepare for a growing pipeline
The unprecedented cost of gene therapies requires a fundamental rethinking of how treatment costs are managed.

GLP-1 agonists: A new class of weight loss medications
In this conversation, discover how new weight loss drugs like Wegovy are changing obesity management and their connection to diabetes.
Top